Intimation regarding the Closure of Trading Window under the SEBI PIT Regulations 2015
Awaiting price reaction for this filing.
Soni Medicare Ltd has informed the stock exchanges that the trading window for its securities will remain closed from 1st January 2026 until 48 hours after the declaration of its unaudited financial results for the quarter ended 31st December 2025 (Q3 FY26). During this period, all Directors, Officers, Designated Persons, and their immediate relatives are prohibited from trading in the company's shares. The company has stated that the exact date of the board meeting to approve the Q3 results will be communicated separately. This is a routine compliance requirement under SEBI's insider trading rules ahead of quarterly results.
No direct impact on shareholders or stock price. This is a standard regulatory filing — the trading window closure simply prevents insiders from trading while they may have access to unpublished financial results, ensuring fair disclosure. Investors should watch for the upcoming Q3 FY26 results announcement, which could be a catalyst for price movement.